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Abstract
Since the spring of 1977, two subtypes of influenza A virus (H3N2 and H1N1) have been seasonally infecting the human
population. In this work we study the distribution of patient ages within the populations that exhibit the symptomatic
disease caused by each of the different subtypes of seasonal influenza viruses. When the publicly available extensive
information is pooled across multiple geographical locations and seasons, striking differences emerge between these
subtypes. We report that the symptomatic flu due to H1N1 is distributed mainly in a younger population relative to H3N2.
(The median age of the H3N2 patients is 23 years while H1N1 patients are 9 years old.) These distinct characteristic spectra
of age groups, possibly carried over from previous pandemics, are consistent with previous reports from various regional
population studies and also findings on the evolutionary dynamics of each subtype. Moreover, they are relevant to age-
related risk assessments, modeling of epidemiological networks for specific age groups, and age-specific vaccine design.
Recently, a novel H1N1 virus has spread around the world. Preliminary reports suggest that this new strain causes
symptomatic disease in the younger population in a similar fashion to the seasonal H1N1 strains.
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Introduction
The year 1918 was marked by the ‘‘Spanish flu’’ H1N1
pandemic that killed more than 50 million people worldwide [1].
The H1N1 virus disappeared from the human population nearly
forty years later, when in 1957 the H2N2 pandemic propagated
around the globe. Except for a few singular reports, such as the
Fort Dix swine flu case in 1976 [2], H1N1 was not isolated from
humans for another 20 years. In May of 1977, the human H1N1
strain reappeared in Northern China [3]. At the time, the main
concern was for the younger population born after 1957, which
had never been exposed to this subtype of the virus. As expected,
the spreading epidemic was almost entirely restricted to the sub-
adult population [4].
Due to improvements in public health conditions, the life
expectancy in Europe and North America has increased. In
contrast however, most probably because of the growing size of the
older population, the US influenza death toll surged fourfold from
1976 to 1999. Older people, along with young children, are
particularly vulnerable to severe outcomes and secondary
infections [5,6].
Over the last few years, the information available in various
public influenza databases has expanded dramatically. This
information, appended to the sequences of viral isolates, includes
the age and sex of the patient, and the date and geographical
location of specimen collection. Thus, the probing of databases to
attempt to uncover demographic trends has become feasible.
Furthermore, the statistical significance of the conclusions that are
drawn is reinforced when the same trends are observed across
independent datasets, and most particularly when datasets are
merged in various combinations.
An important limitation for the collection of a truly random set
of influenza isolates is the fact that not all persons infected by
influenza virus clearly show the symptoms of influenza-like illness
(ILI). Any strain of the virus can infect an individual without
causing acute symptomatic disease. Thus, the content of the
datasets is generally restricted to isolates from persons who were
exhibiting at least fairly severe symptomatic disease, who are
henceforth referred to as ‘‘patients’’ of a given subtype.
Past family and community-based studies, some testing the serum
specimensforantibodiesto the prevalent influenzaviruses andsome
based on a broader interpretation of ILI symptoms, have
demonstrated patterns in age-specific occurrence of illness caused
by the different types and subtypes of influenza virus [7–11]. In
particular, the Houston Family Study, which was conducted from
1977 through 1989, reported a significantly different age distribu-
tions of patients with H1N1 and H3N2 infections, where more than
50% of H1N1 infections were detected among the 10–34 years old
patients and persons born before 1951 had a decreased risk of
developing a virus-positive, medically attended illness. Glezen et al.
[7] attribute this striking difference to the development of lasting
immunity against H1N1 viruses due to exposure to previous
epidemics.
SinceMarch 2009 a new H1N1 strain of influenza A virus of swine
origin has been infecting humans [12]. Most of the patients that show
symptomatic disease from infection by this new strain are also young.
In particular, Kelly et al. [13] report a similar median age of infection
of 2063 years for both the new and the seasonal strains,
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occurrence of illness to geographically diverse populations within
several recent influenza seasons. We analyzed samples from
seasonal influenza in New York State collected by the Wadsworth
Center, New York State Department of Health, and also datasets
entailing temporally and geographically diverse information
deposited in the Influenza Virus Resource of the National Center
for Biotechnology Information (NCBI). [14] The vast majority of
the data, deposited by the Influenza Genome Sequencing Project
of the National Institute of Allergy and Infectious Diseases
(NIAID), are from sequence strains that were not pre-selected
for particular characteristics, such as subtype. [15] Therefore, the
concern regarding unknown biases in sequence datasets can be
mitigated by noting that although the samples were not
methodically collected by a random protocol within the popula-
tion, the number of incidents for both subtypes is sufficiently large
that the bias in the study is reduced. In other words, because the
sequences were not collected with a prior knowledge of the
subtype of the infecting virus, the statistical significance of the
conclusions solely depends on the quantities of the isolates for each
subtype, and their comparability in number. Obviously, the larger
the database, the higher the accuracy of probability estimates.
In this paper, we report a significant dissimilarity, relating to the
patient age distribution of infection, between the two circulating
influenza A subtypes and provide a more robust statistical measure
by combining several datasets and comparing the age distributions
of the influenza A subtypes. Our results are consistent with
previous reports from various population studies and also findings
on the evolutionary dynamics of each subtype.
Methods
We first studied a dataset compiled by the Laboratory of Viral
Diseases at the Wadsworth Center, New York State Department
of Health (NYSDOH). This dataset, which includes the infecting
virus subtype as well as the age and sex of the patient, spans the
influenza A-positive specimens received during the 2006–2007
and 2007–2008 influenza seasons. There are a total of 77 H1N1
and 139 H3N2 isolates in this dataset, the majority of which are
from sentinel physician submissions. The sentinel program, funded
by the Centers for Disease Control and Prevention, has
representative physicians enlisted throughout all regions of New
York State, in various types of clinical practice, who submit
specimens for testing from patients exhibiting influenza-like-illness
throughout the season.
For a more extensive dataset, we acquired a set of sequences for
the hemagglutinin (HA) segment from the H1N1 and H3N2
subtype isolates in the United States from the NCBI public
database. We chose the HA segment solely because of the great
number of available sequences. To try to ensure a high accuracy in
the sequences, we selected ones from large-scale genome-
sequencing projects, and we stipulated that the age and sex of
the patient be available for each isolate. This U.S. dataset contains
512 H1N1 and 1168 H3N2 sequences collected as early as 1995,
although the majority are from 2006–2008. Almost 700 of the
submissions in this dataset from New York State were carefully
selected for temporal and geographical diversity across each of the
seasons from which they were submitted. Additionally, the
majority of these samples originated from sentinel physician
specimens submitted to the Wadsworth Center, as described
above. By applying similar criteria for inclusion, we also acquired a
set of HA sequences from Oceania (mostly from New Zealand)
Table 1. The studied datasets from New York State and the NCBI.
DataSet Season H1N1 H3N2 P(MW)* P(KS)*
Median
a Oldest
b Count
c Median
a Oldest
b Count
c
New York State 2006–2008 21 1947 77 24 1914 139 3.91E-05 4.81E-04
NCBI: United States 2007–2008 21 1948 136 25 1930 478 6.64E-03 5.18E-05
NCBI: United States 2006–2007 7 1940 299 13 1923 77 2.15E-06 1.70E-06
NCBI: United States 1995–2008 9 1928 512 26 1911 1168 3.56E-48 2.15E-50
NCBI: Oceania 2000–2007 20 1923 179 23 1907 586 4.19E-01 4.03E-05
NCBI: All Data 2000–2007 9 1923 583 23 1907 1014 3.77E-18 1.57E-25
a: the median age.
b: the birth year of the oldest person.
c: number of counts.
*Probabilities computed for Mann-Whitney (P(MN)) and Kolmogorov-Smirnov (P(KS)) tests.
doi:10.1371/journal.pone.0006832.t001
Figure 1. Empirical cumulative distribution of ages for patietns
with H1N1 (blue) and H3N2 (red) in New York State during the
2006–2007 and 2007–2008 influenza seasons. The significantly
low probabilities computed via Mann-Whitney (P(MN)) and Kolmo-
gorov-Smirnov (P(KS)) tests indicate a remarkable dissimilarity between
the distributions.
doi:10.1371/journal.pone.0006832.g001
Flu Patient Age Distribution
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2000 to 2007 (see Table 1).
As the information in both NYSDOH and NCBI datasets was
de-identified, no approval from an ethics committee was
necessary. Also, because the NCBI dataset is public and the
NYSDOH dataset only provided the aggregated information, no
patient consent was required.
The number of patients showing symptomatic disease in each of
the age groups is a function of the particular characteristics of the
analyzed subpopulation. For the purpose of assessing the age-trend
differences between the groups contracting influenza caused by
either the H1N1 or H3N2 subtype virus, we employed empirical
cumulative distribution functions in relation to age. To assess the
statistical significance of the trends, we chose the nonparametric
Mann-Whitney and Kolmogorov-Smirnov tests; these respectively
compare the two cumulative distributions via their ranking
difference and their maximum difference.
Results
We first examined age trends in the NYSDOH dataset. When
NYSDOH data from the 2006–2007 and 2007–2008 influenza
seasons were combined, we found that 47% of the detected H1N1
cases were reported in patients younger than 20 years.
Furthermore, only 14% of patients were older than 40 years,
and there were no reports of patients older than 61. The H3N2
strain, on the other hand, was contracted across all age groupings.
Approximately 27% of the reported H3N2 cases were in patients
younger than 20 years, and 27% were reported in patients older
than 40. More than 7% of the patients with symptomatic influenza
caused by subtype H3N2 were older than 80 years. Both statistical
measures confirmed a significant dissimilarity between the age
distributions for the two subtypes: the probabilities that the
observed age trends come from the same distribution are as low as
P(MW)=3.91E-05 and P(KS)=4.81E-04 according to Mann-
Whitney and Kolmogorov-Smirnov tests, respectively (Fig. 1).
When we examined the more extensive NCBI dataset for
similar trends in age distribution among the subtypes, we observed
the following in the 1995–2008 data from the United States (Fig. 2,
left): approximately 76% of the H1N1 patients were younger than
20 years old, and less than 8% were older than 40. There was no
report of any H1N1 patient older than 75 years in our dataset. On
the other hand, roughly 39% of the H3N2 patients were younger
than 20, and 32% were older than 40. Also, slightly less than 11%
were older than 80; the oldest H3N2 patient was 97. Overall, ILI
Figure 2. Empirical cumulative distribution of ages for patients with H1N1 (blue) and H3N2 (red), from the NCBI dataset, in the
United States, between 1995 and 2008 (left) and Oceania, between 2000 and 2007 (right). Complementary to the results from New York
State (Fig. 1), the low probabilities computed via Mann-Whitney (P(MN)) and Kolmogorov-Smirnov (P(KS)) tests show a significant difference between
the distributions, which is spatially and temporally consistent.
doi:10.1371/journal.pone.0006832.g002
Figure 3. Empirical cumulative distribution of ages for patients
with H1N1 (blue) and H3N2 (red), from the NCBI dataset in
United States and Oceania combined, between 2000 and 2007.
The low probabilities computed via Mann-Whitney (P(MN)) and
Kolmogorov-Smirnov (P(KS)) further confirm the results shown in Fig. 2.
doi:10.1371/journal.pone.0006832.g003
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H1N1 caused disease mainly in a younger population. The Mann-
Whitney test applied to the NCBI dataset indicated a significantly
low probability (P(MW)=3.56E-48) that the age distribution was
similar between H1N1 and H3N2. This was confirmed by the
Kolmogorov-Smirnov test, with a very low probability of
P(KS)=2.15E-50.
Analysis of the Oceania dataset also demonstrated the
contrasting age-wise distributions for H1N1 and H3N2. Although,
due to a large number of H3N2 isolates from younger patients,
and a higher variance in the data, the Mann-Whitney test failed
to demonstrate the dissimilarities (P(MW)=4.19E-1), the Kol-
mogorov-Smirnov test did show a significant difference
(P(KS)=4.03E-5) (Fig. 2, right).
Furthermore, combining the Oceania and United States
datasets from years 2000–2007, when there is available data from
both geographical subsets, we see the same kind of disparate age
trends between subtypes: P(MW)=3.77E-18 and P(KS)=1.57
E-25 (Fig. 3).
To refute the possibility that the statistical results could have
arisen due to a unique season, and to check the consistency of the
results within subsets of the data, we also studied each season
individually. The only two seasons in the United States for which
the NCBI database provided data adequate for statistical analysis,
were 2006–2007 and 2007–2008. We again observed different age
trends between influenza subtypes in each of these seasons, and
both the Mann-Whitney and Kolmogorov-Smirnov tests indicated
low probabilities that the distributions were the same (Figs. 4).
In addition, we evaluated the United States dataset from the
NCBI based on the birth year of the patients, in order to
investigate the correlation between the previous pandemics and
possible immunity to one of the subtypes (Fig. 5). Four percent of
the H1N1 patients were born before 1957 (the H2N2 pandemic),
versus 24% of the H3N2 patients; 10% of the H1N1 patients were
born before 1968 (the year of the H3N2 pandemic) versus 32% of
the H3N2 patients. Also, 16% of the H1N1 patients were born
before 1977 (the year of reemergence of H1N1), compared to 42%
of the H3N2 patients. The significant statistical dissimilarity
between the distributions of year of birth (P(MW)=3.33E-22 and
P(KS)=5.89E-34) hints at an existing immunity against one of the
subtypes in different age groups, possibly carried over from a
previous pandemic.
Figure 4. Empirical cumulative distribution of ages for patients with H1N1 (blue) and H3N2 (red), from the NCBI dataset, in United
States during the influenza seasons of 2006–2007 (left) and 2007–2008 (right). The significantly low probabilities computed via Mann-
Whitney (P(MN)) and Kolmogorov-Smirnov (P(KS)) tests during separate influenza seasons show the consistency in our results among sub-portions of
the data and refute the possibility that the previous statistical results are due to a unique season.
doi:10.1371/journal.pone.0006832.g004
Figure 5. Empirical cumulative distribution of birth year for
patients with H1N1 (blue) and H3N2 (red), from the NCBI
dataset, in the United States, between 1995 and 2008. The
significant statistical dissimilarity between the distribution for the year
of birth (P(MW)=2.04E-24 and P(KS)=1.13E-35) hints to an existing
immunity against one of the subtypes in different age groups, possibly
carried over from a previous pandemic.
doi:10.1371/journal.pone.0006832.g005
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We have analyzed the differences in patient age distribution
between influenza A subtypes, using isolates from the 2006–2007
and 2007–2008 influenza seasons in New York State. These data
show a compelling trend that younger persons exhibit ILI caused
by the H1N1 subtype statistically more frequently than do older
persons. We confirmed the results by combining large datasets for
North America and Oceania, from 1995 to 2008, taken from the
NCBI database. The same trend is observed for every year and for
each geographical grouping. These results suggest that the two
influenza subtypes, which are co-circulating around the globe,
target two different age subpopulations with acute illness. These
observations, made within geographically and temporally diverse
datasets, are consistent with findings of the previous regional
populations studies, conducted in the 1970’s and 1980’s, [7] that a
lasting immunity to H1N1 subtypes of influenza virus, possibly
carried over from exposure to previous epidemics and pandemics,
exists in the older population that decreases their risk of developing
the acute symptomatic disease.
These observations also complement some of the previous
findings on the seasonal evolution of influenza A virus. For
example, Rambaut et al. [16], who studied a population that was
spatially and temporally similar to the one in our analysis,
identified a weaker antigenic drift in H1N1, leading to a global co-
circulation of multiple H1N1 lineages and weaker H1N1
bottleneck effects between seasons compared to those of H3N2.
If H1N1 does preferentially target a younger population, as our
results indicate, a lower antigenic pressure and less-severe
bottlenecks in the viral population, are expected. Furthermore,
the different host population of H3N2 could explain the subtype’s
lower diversity and more severe bottlenecks.
In addition, our analysis reflects the morbidity in the current
population, which is also affected by the new H1N1 strain of
influenza A virus that has been infecting humans since March
2009. Interestingly, most of the patients that show symptomatic
disease from infection by this new strain are also young as 60% of
the reported cases are 18 years old or younger [12,17]. This is very
similar to the distribution of age in seasonal H1N1 patients: 69%
in the United States and 49% in Oceania (Figure 2) and 68%
when the Oceania and United States datasets from years 2000–
2007 were combined (Figure 3).
These results are especially pertinent for the assessment of risks
in age-defined subpopulations. For example, in a year when H1N1
is predominant, public health resources should be focused on the
younger populations, by introducing age-specific vaccines. From
the point of view of epidemiological modeling, younger people
have social patterns different from those of the older population,
and it is likely that the two virus subtypes propagate differently in
these distinct networks. This factor again has public health
implications.
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